EP3150198
Lyfjasamsetningar af 3-(6-(1-(2,2-díflúorbensó[d][1,3]díoxól-5-ýl)sýklóprópankarboxamídó)-3-metýlpýridín-2-ýl)bensósýru og gjöf á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.4.2011EP published:
22.9.2021EP application number:
16185289.2
EP translation filed:
18.11.2021Grant published:
15.12.2021EPO information:
European Patent Register
Max expiry date:
6.4.2031Expiry date:
6.4.2027Next due date:
30.4.2027
Title:
PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF
Timeline
Today
7.4.2011EP application
22.9.2021EP Publication
18.11.2021Translation submitted
15.12.2021Registration published
6.4.2027Expires
Owner
Name:
Vertex Pharmaceuticals IncorporatedAddress:
50 Northern Avenue, Boston, MA 02210, US
Inventor
Name:
VERWIJS, Marinus, JacobusAddress:
Framingham, MA Massachusetts 01701, US
Name:
ALARGOVA, Rossitza, GueorguievaAddress:
Brighton, MA Massachusetts 02135, US
Name:
KAUSHIK, Ritu, RohitAddress:
Watertown, MA Massachusetts 02472, US
Name:
KADIYALA, Irina, NikolaevnaAddress:
Newton, MA Massachusetts 02457, US
Name:
YOUNG, Christopher, RyanAddress:
Waltham, MA Massachusetts 02451, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
321729 PDate:
7.4.2010Country:
US
Number:
321748 PDate:
7.4.2010Country:
US
Number:
366562 PDate:
22.7.2010Country:
US
Classification
Categories:
A61K 9/16, A61K 9/20, A61K 9/28, C07D 213/75, C07D 405/12, C07D 405/14
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 21.3.2022
Expires: 6.4.2023
Payer: Patice ehf.
Number: 13
Paid: 21.3.2023
Expires: 6.4.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 19.3.2024
Expires: 6.4.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 8.4.2025
Expires: 6.4.2026
Payer: Árnason Faktor ehf.
Number: 16
Paid: 17.4.2026
Expires: 6.4.2027
Payer: Árnason Faktor ehf.